HanchorBio Inc. (TPEX:7827)

Market Cap	8.16B
Revenue (ttm)	n/a
Net Income (ttm)	-1.07B
Shares Out	119.81M
EPS (ttm)	-10.97
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	715,156
Average Volume	293,348
Open	66.50
Previous Close	66.80
Day's Range	65.70 - 71.20
52-Week Range	41.80 - 95.20
Beta	n/a
RSI	40.29
Earnings Date	n/a

About HanchorBio

HanchorBio Inc. operates as a biotechnology company that develops biologics for cancer patients. The company offers FBDB platform to develop biological medicines. The company also engages in novel target research and evaluation, development of in vitro and in vivo models for evaluating the bioactivities of anti-cancer drugs, and development of proteins. HanchorBio Inc. was founded in 2020 and is based in Taipei, Taiwan with an additional office in Shanghai, China.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2020
• Country: Cayman Islands
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7827